Schedule 13G ownership disclosure

Inhibrx Biosciences Inc

Common Stock · CUSIP: 45720N103

Event date: 2024-12-31

Filing-level shares
831,807
Percent of class
5.7%
  • BlackRock, Inc.

    Shares: 831,807 · Class: 5.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-000635
Form type
SCHEDULE 13G
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Feb 04, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub